Valneva Se (VALN) — 6-K Filings

6-K Filings (50)

• 6-K Filing — May 5, 2026
• Valneva SE Files 6-K with Transaction Documents — Apr 30, 2026 Risk: medium
  Valneva SE filed a Form 6-K on April 30, 2026, reporting for the period ending December 31, 2026. The filing includes a Securities Purchase Agreement (EX-99.1)
• Valneva SE Files Routine 6-K Report for 2026 Period — Mar 26, 2026
  Valneva SE, a French biotechnology company, filed a 6-K on March 26, 2026, indicating a report for the period ending December 31, 2026. This filing, under SEC A
• Valneva SE Files 6-K, Incorporates Press Release — Dec 31, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on December 31, 2025, reporting a press release issued on the same date. This filing incorporates the pres
• Valneva SE Files 6-K with Financial Results Announcement — Dec 11, 2025 Risk: low
  On December 11, 2025, Valneva SE (Valneva) announced its financial results by issuing a press release. This Form 6-K filing incorporates that press release as E
• 6-K Filing — Nov 28, 2025
• Valneva SE Files 6-K with Financial Results — Nov 26, 2025 Risk: low
  On November 26, 2025, Valneva SE (a French biotechnology company) filed a Form 6-K to announce its financial results. The filing includes a press release and un
• 6-K Filing — Nov 20, 2025
• Valneva SE Files 6-K with Press Release — Nov 4, 2025 Risk: low
  On November 4, 2025, Valneva SE filed a Form 6-K, incorporating a press release issued on the same date. This filing is related to their Registration Statement
• Valneva SE Files 6-K, Incorporates Press Release — Oct 6, 2025 Risk: low
  Valneva SE filed a Form 6-K on October 6, 2025, incorporating a press release dated September 30, 2025. This filing is related to their Registration Statement o
• Valneva SE Files 6-K Report — Sep 3, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on September 3, 2025, reporting for the fiscal year ending December 31, 2025. The company is based in Sain
• Valneva SE Files 6-K for FY2025 — Aug 25, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on August 25, 2025. The filing is related to its fiscal year ending December 31, 2025. The company's princ
• Valneva SE Files 6-K for FY 2025 — Aug 18, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on August 18, 2025. The filing is for the period ending December 31, 2025. Valneva SE is incorporated in F
• Valneva SE Files 6-K with Mid-2025 Financials — Aug 12, 2025 Risk: low
  Valneva SE filed a 6-K report on August 12, 2025, detailing its financial position as of June 30, 2025. The report includes financial data for the period ending
• Valneva SE Files 6-K Report — Aug 7, 2025 Risk: low
  Valneva SE, a French biotechnology company, filed a Form 6-K on August 7, 2025. This report is for the period ending December 31, 2025. The company is incorpora
• Valneva SE Files 6-K Report — Jul 11, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on July 11, 2025. The filing is related to its reporting period ending December 31, 2025. The company is i
• Valneva SE Files Routine 6-K with SEC — Jun 26, 2025 Risk: low
  Valneva SE, a French biotechnology company, filed a Form 6-K on June 26, 2025. This report is filed as a foreign private issuer and indicates that Valneva files
• Valneva SE Files 6-K Report — Jun 25, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on June 25, 2025. This report is for the fiscal year ending December 31, 2025. The company is based in Sai
• Valneva SE Files 6-K, Confirms Foreign Private Issuer Status — Jun 5, 2025 Risk: low
  Valneva SE filed a Form 6-K on June 5, 2025, reporting its status as a foreign private issuer. The company, located at 6 rue Alain Bombard, 44800 Saint-Herblain
• Valneva SE Files 6-K, Confirms 20-F Reporting — Jun 4, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on June 4, 2025. The filing indicates that Valneva SE is a foreign private issuer and will file its annual
• Valneva SE Files 6-K Report — May 27, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on May 27, 2025. This report is for the period ending December 31, 2025. The company is incorporated in Fr
• Valneva SE Files 6-K Report — May 12, 2025 Risk: low
  Valneva SE filed a Form 6-K on May 12, 2025, reporting its status as a foreign private issuer. The company, based in Saint-Herblain, France, is involved in the
• Valneva SE Files Q1 2025 Financial Update — May 7, 2025 Risk: low
  Valneva SE filed a 6-K report on May 7, 2025, detailing its financial position as of March 31, 2025. The report includes information on issued capital, share pr
• Valneva SE Files 6-K Report — Apr 28, 2025 Risk: low
  Valneva SE filed a Form 6-K on April 28, 2025, reporting its status as a foreign private issuer. The company, incorporated in France, is in the business of biol
• Valneva SE Files 6-K Report — Apr 18, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on April 18, 2025. The filing is a report of a foreign private issuer and indicates that Valneva files its
• Valneva SE Files 6-K for FY 2025 — Apr 16, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on April 16, 2025, reporting its fiscal year ending December 31, 2025. The company is based in Saint-Herbl
• Valneva SE Files Form 6-K — Apr 14, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on April 14, 2025. The filing indicates that the company is a foreign private issuer and will file its ann
• Valneva SE Files 6-K, Confirms 20-F Filing — Apr 9, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on April 9, 2025. The filing indicates that the company is a foreign private issuer and will file its annu
• Valneva SE Files 6-K, Confirms 20-F Reporting — Apr 1, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on April 4, 2025, reporting its status as a foreign private issuer. The company, incorporated in France wi
• Valneva SE Files 6-K, Confirms 20-F Reporting — Mar 31, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on March 31, 2025, reporting its status as a foreign private issuer. The filing indicates that Valneva wil
• Valneva SE Files 6-K, Confirms 20-F Reporting — Mar 25, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on March 25, 2025. The filing indicates that the company is a foreign private issuer and will file its ann
• Valneva SE Files Routine 6-K Disclosure — Mar 24, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on March 24, 2025, reporting its status as a foreign private issuer. The company, incorporated in France,
• Valneva SE Files 6-K for FY 2025 — Mar 20, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on March 20, 2025, indicating its status as a foreign private issuer filing annual reports under Form 20-F
• Valneva SE Files 6-K Report — Mar 3, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on March 3, 2025, reporting its status as a foreign private issuer. The company, incorporated in I0 with i
• Valneva SE Files 6-K for FY 2025 — Feb 28, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on February 28, 2025. This report is for the fiscal year ending December 31, 2025. The company is register
• Valneva SE Files 6-K for FY 2025 — Feb 18, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on February 18, 2025, reporting its fiscal year ending December 31, 2025. The company is based in Saint-He
• Valneva SE Files Form 6-K for 2025 Period — Feb 5, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on February 5, 2025. This report is for the period ending December 31, 2025. The company is incorporated i
• Valneva SE Files 6-K, Confirms 20-F Filing — Jan 30, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on January 30, 2025. This filing indicates that the company will be filing its annual report under Form 20
• Valneva SE Files 6-K Report — Jan 23, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on January 23, 2025, reporting its status as a foreign private issuer. The company is incorporated in Fran
• Valneva SE Files 6-K for FY 2025 — Jan 21, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on January 21, 2025. This report is for the fiscal year ending December 31, 2025. The company is based in
• Valneva SE Files 6-K, Confirms 20-F Reporting — Jan 7, 2025 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on January 7, 2025, reporting its status as a foreign private issuer. The filing indicates that Valneva wi
• Valneva SE Files 6-K, Confirms 20-F Reporting — Dec 19, 2024 Risk: low
  Valneva SE, a European biotechnology company, filed a Form 6-K on December 19, 2024. The filing indicates that Valneva SE is a foreign private issuer and will f
• Valneva SE Files 6-K, Confirms 20-F Reporting — Dec 4, 2024 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on December 4, 2024. This report is filed as a foreign private issuer and indicates that the company files
• Valneva SE Files 6-K, Confirms 20-F Reporting — Dec 3, 2024 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on December 3, 2024. This report is filed as a foreign private issuer and indicates that Valneva files its
• Valneva SE Files Form 6-K — Nov 26, 2024 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on November 26, 2024. This report is filed under the Securities Exchange Act of 1934, indicating it's a re
• Valneva SE Files 6-K Report — Nov 13, 2024 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on November 13, 2024. The filing is a report of a foreign private issuer and indicates that Valneva files
• Valneva SE Files Q3 2024 Financial Update — Nov 7, 2024 Risk: low
  Valneva SE filed a 6-K report for the period ending September 30, 2024. The filing includes financial data for the nine months ended September 30, 2024, and com
• Valneva SE Files 6-K, Confirms 20-F Reporting — Oct 21, 2024 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on October 21, 2024. This report is for foreign private issuers and indicates that Valneva files its annua
• Valneva SE Files Form 6-K — Oct 16, 2024 Risk: low
  Valneva SE, a biotechnology company, filed a Form 6-K on October 16, 2024. The filing indicates that Valneva SE is a foreign private issuer and will file its an
• Valneva SE Files Form 6-K — Oct 10, 2024 Risk: low
  Valneva SE, a French biotechnology company, filed a Form 6-K on October 10, 2024. This report is for foreign private issuers and indicates that Valneva files it

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX